2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid

C97H120N16O18S — CID 134213800

IUPAC2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)C(Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C
InChIInChI=1S/C97H120N16O18S/c1-11-12-36-78-95(129)110(7)55-83(117)102-74(51-85(119)120)91(125)108-86(59(4)5)97(131)112(9)79(48-61-28-18-14-19-29-61)92(126)106-75(46-63-38-41-68(114)42-39-63)93(127)109(6)54-82(116)101-73(50-67-52-99-70-35-25-24-34-69(67)70)90(124)105-72(47-64-37-40-65-32-22-23-33-66(65)44-64)89(123)104-71(43-58(2)3)88(122)107-77(87(121)100-53-81(98)115)56-132-57-84(118)103-76(45-60-26-16-13-17-27-60)94(128)113(10)80(96(130)111(78)8)49-62-30-20-15-21-31-62/h13-35,37-42,44,52,58-59,71-80,86,99,114H,11-12,36,43,45-51,53-57H2,1-10H3,(H2,98,115)(H,100,121)(H,101,116)(H,102,117)(H,103,118)(H,104,123)(H,105,124)(H,106,126)(H,107,122)(H,108,125)(H,119,120)/t71-,72-,73-,74-,75-,76-,77-,78-,79?,80-,86-/m0/s1
InChIKeyNFVSFGNBADTXMI-WDRRQCNUSA-N
MW1830.19 g/mol
LogP3.77
Rot. Bonds23

About 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid

2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid (PubChem CID 134213800) has the molecular formula C97H120N16O18S and a molecular weight of 1830.19 g/mol. Its IUPAC name is 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid.

Molecular Properties

Compound Name2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
PubChem CID134213800
Molecular FormulaC97H120N16O18S
Molecular Weight1830.19 g/mol
Exact Mass1828.87
IUPAC Name2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)C(Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C
InChIInChI=1S/C97H120N16O18S/c1-11-12-36-78-95(129)110(7)55-83(117)102-74(51-85(119)120)91(125)108-86(59(4)5)97(131)112(9)79(48-61-28-18-14-19-29-61)92(126)106-75(46-63-38-41-68(114)42-39-63)93(127)109(6)54-82(116)101-73(50-67-52-99-70-35-25-24-34-69(67)70)90(124)105-72(47-64-37-40-65-32-22-23-33-66(65)44-64)89(123)104-71(43-58(2)3)88(122)107-77(87(121)100-53-81(98)115)56-132-57-84(118)103-76(45-60-26-16-13-17-27-60)94(128)113(10)80(96(130)111(78)8)49-62-30-20-15-21-31-62/h13-35,37-42,44,52,58-59,71-80,86,99,114H,11-12,36,43,45-51,53-57H2,1-10H3,(H2,98,115)(H,100,121)(H,101,116)(H,102,117)(H,103,118)(H,104,123)(H,105,124)(H,106,126)(H,107,122)(H,108,125)(H,119,120)/t71-,72-,73-,74-,75-,76-,77-,78-,79?,80-,86-/m0/s1
InChIKeyNFVSFGNBADTXMI-WDRRQCNUSA-N
XLogP3.77
TPSA479.86 Ų
H-Bond Donors13
H-Bond Acceptors18
Rotatable Bonds23
Heavy Atoms132
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001830.19
LogP ≤ 53.77
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1018

Analyze 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The IUPAC name of 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid (CID 134213800) is 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid.
What is the SMILES notation for 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The canonical SMILES for 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid is CCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)C(Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C.
What is the InChIKey of 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The InChIKey is NFVSFGNBADTXMI-WDRRQCNUSA-N. The full InChI is InChI=1S/C97H120N16O18S/c1-11-12-36-78-95(129)110(7)55-83(117)102-74(51-85(119)120)91(125)108-86(59(4)5)97(131)112(9)79(48-61-28-18-14-19-29-61)92(126)106-75(46-63-38-41-68(114)42-39-63)93(127)109(6)54-82(116)101-73(50-67-52-99-70-35-25-24-34-69(67)70)90(124)105-72(47-64-37-40-65-32-22-23-33-66(65)44-64)89(123)104-71(43-58(2)3)88(122)107-77(87(121)100-53-81(98)115)56-132-57-84(118)103-76(45-60-26-16-13-17-27-60)94(128)113(10)80(96(130)111(78)8)49-62-30-20-15-21-31-62/h13-35,37-42,44,52,58-59,71-80,86,99,114H,11-12,36,43,45-51,53-57H2,1-10H3,(H2,98,115)(H,100,121)(H,101,116)(H,102,117)(H,103,118)(H,104,123)(H,105,124)(H,106,126)(H,107,122)(H,108,125)(H,119,120)/t71-,72-,73-,74-,75-,76-,77-,78-,79?,80-,86-/m0/s1.
What are the key properties of 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid has a molecular weight of 1830.19 g/mol, XLogP of 3.77, 23 rotatable bonds, 13 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5S,8S,11S,17S,20S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26-[(4-hydroxyphenyl)methyl]-32-(1H-indol-3-ylmethyl)-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-35-(naphthalen-2-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid is sourced from PubChem (CID 134213800), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).